115 related articles for article (PubMed ID: 20948218)
21. Early recanalization rate of major occluded brain arteries after intravenous tissue plasminogen activator therapy using serial magnetic resonance angiography studies.
Kimura K; Iguchi Y; Shibazaki K; Aoki J; Uemura J
Eur Neurol; 2009; 62(5):287-92. PubMed ID: 19713704
[TBL] [Abstract][Full Text] [Related]
22. Systemic thrombolysis with rt-PA in patients under 40 years of age: a subgroup analysis of the Cologne Stroke Experience.
Galldiks N; Zaro-Weber O; Dohmen C; Neveling M; Haupt WF; Fink GR; Sobesky J
Cerebrovasc Dis; 2010; 30(5):514-8. PubMed ID: 20861623
[TBL] [Abstract][Full Text] [Related]
23. [Simple and effective rt-PA thrombolysis design].
Cejna M; Salomonowitz E; Wohlschlager H; Zwrtek K; Böck R
Rofo; 1998 Nov; 169(5):521-5. PubMed ID: 9849604
[TBL] [Abstract][Full Text] [Related]
24. Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.
Hattenbach LO; Friedrich Arndt C; Lerche R; Scharrer I; Baatz H; Margaron F; Richard G; Behrens-Baumann W; Ohrloff C
Retina; 2009; 29(7):932-40. PubMed ID: 19584651
[TBL] [Abstract][Full Text] [Related]
25. Multimodality MRI and MRA for decision making in minor stroke: a case with internal carotid and distal middle cerebral artery occlusion.
Beitzke M; Enzinger C; Beitzke D; Niederkorn K; Offenbacher H; Niederkorn-Duft M; Fazekas F
J Neuroimaging; 2011 Apr; 21(2):e156-8. PubMed ID: 20572908
[TBL] [Abstract][Full Text] [Related]
26. Systemic thrombolysis based on CT or MRI stroke imaging.
Veronel D; Ringelstein A; Cohnen M; Yong M; Siebler M; Seitz RJ
J Neuroimaging; 2008 Oct; 18(4):381-7. PubMed ID: 18494775
[TBL] [Abstract][Full Text] [Related]
27. Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator?
Hassan AE; Zacharatos H; Hassanzadeh B; El-Gengaihy A; AlKawi A; Shhadeh A; Kirmani JF
J Stroke Cerebrovasc Dis; 2010 Mar; 19(2):116-20. PubMed ID: 20189087
[TBL] [Abstract][Full Text] [Related]
28. Exacerbation of perihematomal edema and sterile meningitis with intraventricular administration of tissue plasminogen activator in patients with intracerebral hemorrhage.
Ducruet AF; Hickman ZL; Zacharia BE; Grobelny BT; Narula R; Guo KH; Claassen J; Lee K; Badjatia N; Mayer SA; Connolly ES
Neurosurgery; 2010 Apr; 66(4):648-55. PubMed ID: 20305489
[TBL] [Abstract][Full Text] [Related]
29. Recanalization of the MCA should play an important role in dramatic recovery after t-PA therapy in patients with ICA occlusion.
Kimura K; Iguchi Y; Shibazaki K; Iwanaga T; Aoki J
J Neurol Sci; 2009 Oct; 285(1-2):130-3. PubMed ID: 19573877
[TBL] [Abstract][Full Text] [Related]
30. Endogenous activated protein C predicts hemorrhagic transformation and mortality after tissue plasminogen activator treatment in stroke patients.
Mendioroz M; Fernández-Cadenas I; Alvarez-Sabín J; Rosell A; Quiroga D; Cuadrado E; Delgado P; Rubiera M; Ribó M; Molina C; Montaner J
Cerebrovasc Dis; 2009; 28(2):143-50. PubMed ID: 19546541
[TBL] [Abstract][Full Text] [Related]
31. Failed recovery from thrombolysis is predicted by the initial diffusion weighted imaging lesion.
Seitz RJ; Oberstrass H; Ringelstein A; Wittsack HJ; Siebler M
Cerebrovasc Dis; 2011; 31(6):580-7. PubMed ID: 21487223
[TBL] [Abstract][Full Text] [Related]
32. Combined intravenous recombinant-tissular plasminogen activator and endovascular treatment of spontaneous occlusive internal carotid dissection with tandem intracranial artery occlusion.
Lekoubou A; Cho TH; Nighoghossian N; Kumako V; Derex L; Trouillas P; Turjman F
Eur Neurol; 2010; 63(4):211-4. PubMed ID: 20215752
[TBL] [Abstract][Full Text] [Related]
33. Intravenous thrombolysis in proximal middle cerebral artery occlusion.
Schneweis S; Grond M; Neveling M; Schmülling S; Rudolf J; Heiss WD
Cerebrovasc Dis; 2001; 11(3):212-5. PubMed ID: 11306770
[TBL] [Abstract][Full Text] [Related]
34. Dramatic changes of a DWI lesion in a patient with acute ischemic stroke treated with IV t-PA.
Sakamoto Y; Kimura K; Iguchi Y; Shibazaki K; Aoki J
J Neuroimaging; 2013 Apr; 23(2):228-30. PubMed ID: 21848677
[TBL] [Abstract][Full Text] [Related]
35. Intraventricular tissue plasminogen activator toxicity.
Gaberel T; Emery E
Neurosurgery; 2011 Jan; 68(1):E288-9; author reply E289. PubMed ID: 21150745
[No Abstract] [Full Text] [Related]
36. Successful intravenous thrombolysis in acute ischaemic stroke in a patient on rivaroxaban treatment.
Kawiorski MM; Alonso-Canovas A; de Felipe Mimbrera A; Sainz de la Maza S; Alvarez-Velasco R; Zarza B; Masjuan J
Thromb Haemost; 2014 Mar; 111(3):557-8. PubMed ID: 24196421
[No Abstract] [Full Text] [Related]
37. Is the Susceptibility Vessel Sign on 3-Tesla Magnetic Resonance T2*-Weighted Imaging a Useful Tool to Predict Recanalization in Intravenous Tissue Plasminogen Activator?
Yamamoto N; Satomi J; Harada M; Izumi Y; Nagahiro S; Kaji R
Clin Neuroradiol; 2016 Sep; 26(3):317-23. PubMed ID: 25516146
[TBL] [Abstract][Full Text] [Related]
38. Use of intravenous recombinant tissue plasminogen activator in patients outside the defined criteria: safety and feasibility issues.
Matz K; Brainin M
Expert Rev Neurother; 2013 Feb; 13(2):177-85. PubMed ID: 23368805
[TBL] [Abstract][Full Text] [Related]
39. Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial.
Schumacher M; Schmidt D; Jurklies B; Gall C; Wanke I; Schmoor C; Maier-Lenz H; Solymosi L; Brueckmann H; Neubauer AS; Wolf A; Feltgen N;
Ophthalmology; 2010 Jul; 117(7):1367-75.e1. PubMed ID: 20609991
[TBL] [Abstract][Full Text] [Related]
40. [Thrombolysis of acute arterial occlusion with rt PA].
Kurtoğlu M; Granit V; Necefli A; Kurtoğlu M; Güloğlu R
Ulus Travma Derg; 2001 Jul; 7(3):158-62. PubMed ID: 11705216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
